Metabolic bone disease in the context of metastatic neuroendocrine tumor: differentiation from skeletal metastasis, the molecular PET-CT imaging features, and exploring the possible etiopathologies including parathyroid adenoma (MEN1) and paraneoplastic humoral hypercalcemia of malignancy due to PTHrp hypersecretion

Three cases of metabolic bone disease in the setting of metastatic neuroendocrine tumor (NET) are illustrated with associated etiopathologies. One of these cases harbored mixed lesions in the form of vertebral metastasis (biopsy proven) while the other skeletal lesions were caused due to metabolic...

Full description

Bibliographic Details
Main Authors:	Rohit Ranade, Sandip Basu
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	World Journal of Nuclear Medicine
Subjects:	Bone metastasis humoral hypercalcemia of malignancy metabolic bone disease metastatic neuroendocrine tumor multiple endocrine neoplasia type I syndrome peptide receptor radionuclide therapy 68Ga-DOTATATE positron emission tomography-computed tomography 18F-fluoride PET-CT
Online Access:	http://www.wjnm.org/article.asp?issn=1450-1147;year=2017;volume=16;issue=1;spage=62;epage=67;aulast=Ranade

Internet

http://www.wjnm.org/article.asp?issn=1450-1147;year=2017;volume=16;issue=1;spage=62;epage=67;aulast=Ranade

Internet

Similar Items